Progetto di ricerca

USAID INVEST PROJECT (DSB.AD001.220)

Area tematica

Scienze biomediche

Area progettuale

Oncologia e Immunologia (DSB.AD001)

Struttura responsabile del progetto di ricerca

Istituto di fisiologia clinica (IFC)

Responsabile di progetto

SILVESTRO CONTICELLO
Telefono: 0503152216
E-mail: silvoc@ifc.cnr.it

Abstract

According to the World Health Organization, as of 14 July 2020, near 13 million cases of COVID-19
have been reported worldwide, with over 560,000 deaths1
. As some mitigation efforts begin to relax,it is imperative that COVID-19 response efforts remain in place, and that countries prepare for longer-term effects of the initial outbreak.
Italy was among the earliest of countries to report cases of COVID-19 and was badly affected. While the number of new cases has flattened, and the country opens back up, Italy remains vigilant in ensuring enough supply and distribution of personal protective equipment (PPE), medical supplies, and appropriate linkages to healthcare service delivery. Italy plans to continually decrease cases as well as to prepare for a possible second wave and long-term effects of the pandemic. However, with infections increasing in other countries Italy's ability to access medical supplies in the global market is weakened, since many countries restrict export of medical supplies to serve their own populations or direct them to regions with urgent outbreak needs.

Obiettivi

IMPLEMENTATION OBJECTIVES
Through a subcontract, USAID will use strategic amounts of U.S. foreign assistance to leverage
larger amounts of private sector capital for greater social and economic impact. To address the
bottlenecks that impact the ability of Italian firms to ramp up production and distribution of personal protective equipment (PPE) and other COVID-19 products and services, USAID will use a twopronged, concurrent approach supported by international development aid funding. Component 1
focuses on catalytic capital to help reduce risk for private investors and stimulate investment to ramp up manufacturing of PPE and medical supplies required to address short- and long-term COVID-19
demands. Component 2 focuses on providing technical assistance to help companies address
technical, operational, and financial challenges that may be inhibiting COVID-19 response.

Data inizio attività

18/08/2020

Parole chiave

USAID, INVEST PROJECT

Ultimo aggiornamento: 15/06/2025